FF — Fine Foods & Pharmaceuticals NTM SpA Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeSmall CapNeutral

Market Cap
€217.61m
Enterprise Value
€269.24m
Revenue
€243.75m

Annual income statement for Fine Foods & Pharmaceuticals NTM SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	172	195	207	252	244
Cost of Revenue
Gross Profit	48.6	56.1	54.5	68.8	79.7
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	162	190	208	251	229
Operating Profit	9.48	5.03	-1.01	1.07	14.6
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	16.7	-4.59	-14.2	-1.86	11.8
Provision for Income Taxes
Net Income After Taxes	13.4	-1.43	-9.5	-3.52	8.16
Net Income Before Extraordinary Items
Net Income	13.4	-1.43	-9.5	-3.52	8.16
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	13.4	-1.43	-9.5	-3.52	8.16
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.591	-0.024	-0.345	0.005	0.416
Dividends per Share